>MedPage Today ORLANDO A biosimilar of adalimumab Humira was comparable to the drug to treat Crohn's disease a researcher said here.The biosimilar BI 695501 Boehringer Ingelheim demonstrated noninferiority in terms of efficacy compared...
↧